Asthma Home > Metaproteranol
Were you looking for information on Metaproterenol? Metaproteranol is a common misspelling of metaproterenol.
Metaproterenol is no longer available in the United States. The manufacturer of this medication decided to stop making it in order to comply with regulations concerning chlorofluorocarbons (CFCs), chemicals that may deplete the ozone layer. The product was rarely used anymore; had it been more popular, the manufacturer probably would have chosen to reformulate it without CFCs, instead of just discontinuing it.
A healthcare provider may prescribe metaproterenol (Alupent®) to treat bronchospasms caused by asthma or chronic obstructive pulmonary disease (COPD). The drug works by opening up the airways so that more air can get into and through the lungs. In clinical studies, metaproterenol started working within five minutes, and its effects typically lasted for five hours. Most people tolerate the drug well, but side effects are possible. Common ones include dizziness, headaches, and heart palpitations.
(For more information, click Metaproterenol. Topics include how the drug is taken, what to discuss with your healthcare provider before starting treatment, and what to expect in case of an overdose.)